Yondelis trabectedin: Interim Phase III data

Interim data from the open-label, international Phase III SAR3007 trial in 518 patients with advanced liposarcoma or leiomyosarcoma who were previously treated with an anthracycline and >=1 additional chemotherapy regimen

Read the full 302 word article

How to gain access

Continue reading with a
two-week free trial.